The cost of bringing an FIC Drug to market (2009 - 2018)

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
kmall
Posts: 753
Joined: Thu Mar 21, 2019 3:57 pm

The cost of bringing an FIC Drug to market (2009 - 2018)

Post by kmall » Tue Jan 03, 2023 9:04 am

https://jamanetwork.com/journals/jama/f ... %20billion.

"The most widely cited studies of the cost of developing a new drug (DiMasi et al3,4) reported a sharp increase in the mean cost of developing a single new therapeutic agent from $1.1 billion in 2003 to $2.8 billion in 2013 (in 2018 US dollars), based on a real cost of capital rate of 11% per year in the former study3 and of 10.5% per year in the latter.4"


"Accurate information on costs of failures, ie, research and development outlays on candidates being developed by companies but not ultimately approved, is essential to estimating the costs of drug development. We accounted for failures using data on aggregate clinical trial success rates from a recent study by Wong et al (Table 1).18"


"Estimates differed across therapeutic areas, with costs of developing cancer drugs the highest. The results included costs of failed clinical trials and varied in sensitivity analyses using different estimates of trial success, preclinical expenditures, and cost of capital."


*In business, the goal is to sell for a profit. Not simply to break even. -Kmall

Post Reply